NYSE · Medical - Equipment & Services

CON (CON) Stock

$30.76 -1.16% NYSE: CON Healthcare

Valuation

MetricValue
Price$30.76
Market Cap$3.94B
P/E Ratio19.32
P/B Ratio8.18
P/S Ratio1.45
EPS (TTM)$0.00
52-Week High$32.34
52-Week Low$18.55
Dividend Yield0.99%

Financials & Margins

MetricValue
ROE44.02%
ROA5.69%
ROCE497.14%
Gross Margin96.49%
Operating Margin96.53%
Net Margin7.97%
Debt/Equity5.00
Current Ratio1.14

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.7B$1.7B$1.8B$1.9B$2.2B
Operating Profit$270.0M$258.0M$288.0M$305.0M$2.1B
Net Profit$209.0M$167.0M$180.0M$167.0M$173.0M
EPS$1.65$1.32$1.42$1.30$1.30
Op Margin15.6%15.0%15.7%16.0%96.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets—$2.3B$2.5B$2.5B$3.0B
Total Liabilities—$1.3B$1.3B$2.2B$2.6B
Cash—$38.0M$31.0M$183.0M$80.0M
Borrowings$0$1.0B$905.0M$2.0B$2.1B

Latest News

CON vs. MEDP: Which Stock Is the Better Value Option? Zacks · Jul 15, 2026 CON: Lowering target price to $32.00 Argus Research · Jul 15, 2026 Truist Raises Price Target on Concentra Group Holdings Parent to $37 From $31, Keeps Buy Rating MT Newswires · Jul 14, 2026 Concentra Expands Near Kansas City International Airport with New Medical Center Business Wire · Jul 13, 2026 Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026 Business Wire · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$291.0M$274.0M$234.0M$275.0M$279.0M
Investing Cash Flow$-109.0M$-104.0M$-145.0M$-136.0M$-497.0M
Financing Cash Flow$-16.0M$-25.0M$-1.0M$-19.0M$-26.0M
Net Cash Flow$-114.0M$7.0M$-6.0M$152.0M$-103.0M
Free Cash Flow$244.0M$228.0M$165.0M$210.0M$197.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA2.42
FCF Yield9.05%
Quick Ratio1.26
Interest Coverage19.16
Return 1Y60.46%
Return 3Y—
Return 5Y—

Ownership

Insiders Held10.73%
Institutions Held87.82%
Institutions Float Held98.38%
Institutional HolderSharesReport Date
Blackrock Inc.17,067,3502026-03-31
Price (T.Rowe) Associates Inc17,036,8622026-03-31
Vanguard Portfolio Management LLC6,738,9252026-03-31
Vanguard Capital Management LLC5,095,5162026-03-31
State Street Corporation4,602,8252026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADUS $116.46 +2.46% 17.77 $2.17B 0.00%
BEAM $25.62 +2.19% -35.36 $2.64B 0.00%
BHCBausch Health Companies Inc. $4.58 +3.27% -1.38 $1.71B 0.00%
CPRX $31.49 +0.00% 18.00 $3.85B 0.00%
HAE $83.60 -2.08% 37.62 $3.80B 0.00%

About CON

CON stock trades at $30.76 with a market capitalization of $3.94B. The stock is valued at a price-to-earnings (P/E) ratio of 19.32, price-to-book of 8.18, price-to-sales of 1.45. Over the past 52 weeks the stock has ranged between $18.55 and $32.34, and currently trades 4.9% below its 52-week high. It pays a dividend yielding 0.99%.

On profitability, CON generates a return on equity (ROE) of 44.02% — well above the market average, a sign of a high-quality business, return on capital employed of 497.14%, an operating margin of 96.53%, a net profit margin of 7.97%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides